Home LiteratureArticle Details
PMID: 16845475 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Earliest changes in the left ventricular transcriptome postmyocardial infarction.

Harpster MH, Bandyopadhyay S, Thomas DP, Ivanov PS, Keele JA, Pineguina N, Gao B, Amarendran V, Gomelsky M, McCormick RJ, Stayton MM

Abstract

We report a genome-wide survey of early responses of the mouse heart transcriptome to acute myocardial infarction (AMI). For three regions of the left ventricle (LV), namely, ischemic/infarcted tissue (IF), the surviving LV free wall (FW), and the interventricular septum (IVS), 36,899 transcripts were assayed at six time points from 15 min to 48 h post-AMI in both AMI and sham surgery mice. For each transcript, temporal expression patterns were systematically compared between AMI and sham groups, which identified 515 AMI-responsive genes in IF tissue, 35 in the FW, 7 in the IVS, with three genes induced in all three regions. Using the literature, we assigned functional annotations to all 519 nonredundant AMI-induced genes and present two testable models for central signaling pathways induced early post-AMI. First, the early induction of 15 genes involved in assembly and activation of the activator protein-1 (AP-1) family of transcription factors implicates AP-1 as a dominant regulator of earliest post-ischemic molecular events. Second, dramatic increases in transcripts for arginase 1 (ARG1), the enzymes of polyamine biosynthesis, and protein inhibitor of nitric oxide synthase (NOS) activity indicate that NO production may be regulated, in part, by inhibition of NOS and coordinate depletion of the NOS substrate, L: -arginine. ARG1: was the single-most highly induced transcript in the database (121-fold in IF region) and its induction in heart has not been previously reported.

MeSH Terms
Acute Disease Algorithms Animals Arginase/genetics Gene Expression Profiling Heart Ventricles/metabolism Male Mice Mice, Inbred C57BL Myocardial Infarction/genetics,metabolism Nitric Oxide/biosynthesis Transcription Factor AP-1/genetics
Chemicals
Transcription Factor AP-1 Nitric Oxide Arginase
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Harpster Mark H
Department of Molecular Biology, University of Wyoming, Laramie, 82071, USA.
Bandyopadhyay Somnath
Thomas D Paul
Ivanov Pavel S
Keele Jacque A
Pineguina Natalia
Gao Bifeng
Amarendran Vijay
Gomelsky Mark
McCormick Richard J
Stayton Mark M
References (81)
81 references, click to expand
  1. Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray.
    Am J Pathol. 2002 Jun;160(6):2035-43 PMID: 12057908
  2. Interleukin-1 costimulatory activity on the interleukin-2 promoter via AP-1.
    Science. 1989 Oct 13;246(4927):249-51 PMID: 2799385
  3. Recent advances in arginine metabolism.
    Curr Opin Clin Nutr Metab Care. 2004 Jan;7(1):45-51 PMID: 15090903
  4. Disruption of the c-JUN-JNK complex by a cell-permeable peptide containing the c-JUN delta domain induces apoptosis and affects a distinct set of interleukin-1-induced inflammatory genes.
    J Biol Chem. 2003 Oct 10;278(41):40213-23 PMID: 12832416
  5. Late ischemic preconditioning of the myocardium alters the expression of genes involved in inflammatory response.
    FEBS Lett. 2003 Jul 17;547(1-3):51-5 PMID: 12860385
  6. Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure.
    Cardiovasc Res. 2003 Mar;57(3):749-56 PMID: 12618236
  7. Genetic basis for chamber-specific ventricular phenotypes in the rat infarct model.
    Cardiovasc Res. 2003 Feb;57(2):477-85 PMID: 12566120
  8. Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats.
    Cardiovasc Res. 1998 Apr;38(1):116-24 PMID: 9683913
  9. Dominant negative mutant of c-Jun inhibits cardiomyocyte hypertrophy induced by endothelin 1 and phenylephrine.
    Hypertension. 2002 Jan;39(1):81-6 PMID: 11799083
  10. cDNA array hybridization reveals cardiac gene expression in acute ischemic murine hearts.
    Cardiovasc Drugs Ther. 2001 Mar;15(2):125-30 PMID: 11669405
  11. Molecular dynamics of the compensatory response to myocardial infarct.
    J Mol Cell Cardiol. 2005 Jan;38(1):103-17 PMID: 15623427
  12. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.
    Circulation. 2001 Oct 2;104(14):1670-5 PMID: 11581147
  13. Mitogen-activated protein kinases and activator protein 1 are required for proliferation and cardiomyocyte differentiation of P19 embryonal carcinoma cells.
    J Biol Chem. 2002 May 3;277(18):15992-6001 PMID: 11884386
  14. Altered patterns of gene expression in response to myocardial infarction.
    Circ Res. 2000 May 12;86(9):939-45 PMID: 10807865
  15. AP-1 in mouse development and tumorigenesis.
    Oncogene. 2001 Apr 30;20(19):2401-12 PMID: 11402336
  16. Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase.
    FASEB J. 2003 Dec;17(15):2328-30 PMID: 14563685
  17. AP-1 as a regulator of cell life and death.
    Nat Cell Biol. 2002 May;4(5):E131-6 PMID: 11988758
  18. Control of stochasticity in eukaryotic gene expression.
    Science. 2004 Jun 18;304(5678):1811-4 PMID: 15166317
  19. Polyamines protect Escherichia coli cells from the toxic effect of oxygen.
    Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2261-5 PMID: 12591940
  20. Cobalt chloride induces delayed cardiac preconditioning in mice through selective activation of HIF-1alpha and AP-1 and iNOS signaling.
    Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2369-75 PMID: 15284066
  21. Antizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression.
    Biochem J. 2000 Mar 15;346 Pt 3:699-704 PMID: 10698696
  22. Restriction-mediated differential display (RMDD) identifies pip92 as a pro-apoptotic gene product induced during focal cerebral ischemia.
    J Cereb Blood Flow Metab. 2004 Feb;24(2):224-36 PMID: 14747749
  23. Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure.
    Physiol Genomics. 2002 Jul 12;10(1):31-44 PMID: 12118103
  24. Transcriptomal analysis of failing and nonfailing human hearts.
    Physiol Genomics. 2003 Jan 15;12(2):97-112 PMID: 12429867
  25. Rapid upregulation of CTGF in cardiac myocytes by hypertrophic stimuli: implication for cardiac fibrosis and hypertrophy.
    J Mol Cell Cardiol. 2004 Aug;37(2):477-81 PMID: 15276017
  26. Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy.
    Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):669-74 PMID: 12515860
  27. The EAT/mcl-1 gene, an inhibitor of apoptosis, is up-regulated in the early stage of acute myocardial infarction.
    Biochim Biophys Acta. 1999 Nov 16;1472(3):471-8 PMID: 10564761
  28. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.
    Bioinformatics. 2003 Jan 22;19(2):185-93 PMID: 12538238
  29. Elucidating the molecular mechanism of cardiac remodeling using a comparative genomic approach.
    Physiol Genomics. 2003 Oct 17;15(2):115-26 PMID: 12902547
  30. Update on mechanism and catalytic regulation in the NO synthases.
    J Biol Chem. 2004 Aug 27;279(35):36167-70 PMID: 15133020
  31. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays.
    Circulation. 2000 Dec 19;102(25):3046-52 PMID: 11120693
  32. Glucose utilization is essential for hypoxia-inducible factor 1 alpha-dependent phosphorylation of c-Jun.
    Mol Cell Biol. 2004 May;24(10):4128-37 PMID: 15121835
  33. Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes.
    Cardiovasc Res. 2004 Aug 15;63(3):545-52 PMID: 15276480
  34. Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation.
    Circ Res. 1999 Oct 29;85(9):829-40 PMID: 10532951
  35. Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes.
    Mol Cell Biol. 2004 Feb;24(3):1081-95 PMID: 14729955
  36. Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death.
    J Clin Invest. 2002 Mar;109(6):735-43 PMID: 11901182
  37. ProBNP-derived peptides in cardiac disease.
    Scand J Clin Lab Invest. 2004;64(5):497-510 PMID: 15276915
  38. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo.
    Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3328-33 PMID: 11248078
  39. Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component?
    Philos Trans R Soc Lond B Biol Sci. 2004 Jun 29;359(1446):1021-44 PMID: 15306414
  40. A perspective of polyamine metabolism.
    Biochem J. 2003 Nov 15;376(Pt 1):1-14 PMID: 13678416
  41. Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways.
    J Clin Invest. 2001 Nov;108(10 ):1459-67 PMID: 11714737
  42. Cytoplasmic signaling pathways that regulate cardiac hypertrophy.
    Annu Rev Physiol. 2001;63:391-426 PMID: 11181961
  43. Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload.
    Physiol Genomics. 2003 Jan 15;12(2):113-27 PMID: 12454204
  44. Akt-dependent phosphorylation specifically regulates Cot induction of NF-kappa B-dependent transcription.
    Mol Cell Biol. 2002 Aug;22(16):5962-74 PMID: 12138205
  45. The protein inhibitor of neuronal nitric oxide synthase (PIN): characterization of its action on pure nitric oxide synthases.
    FEBS Lett. 1998 Jul 3;430(3):397-400 PMID: 9688579
  46. Identification of IEX-1 as a biomechanically controlled nuclear factor-kappaB target gene that inhibits cardiomyocyte hypertrophy.
    Circ Res. 2002 Apr 5;90(6):690-6 PMID: 11934837
  47. Gene program for cardiac cell survival induced by transient ischemia in conscious pigs.
    Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9336-41 PMID: 11481491
  48. A chronic mouse model of myocardial ischemia-reperfusion: essential in cytokine studies.
    Am J Physiol Heart Circ Physiol. 2000 Apr;278(4):H1049-55 PMID: 10749697
  49. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms.
    Nature. 2002 Mar 21;416(6878):337-9 PMID: 11907582
  50. Determination of arginase activity in macrophages: a micromethod.
    J Immunol Methods. 1994 Sep 14;174(1-2):231-5 PMID: 8083527
  51. Gene expression profile in mouse myocardium after ischemia.
    Physiol Genomics. 2000 Apr 27;2(3):93-100 PMID: 11015587
  52. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.
    Cell. 1998 Apr 17;93(2):215-28 PMID: 9568714
  53. Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies.
    Physiol Genomics. 2004 Feb 13;16(3):349-60 PMID: 14679301
  54. A novel human STE20-related protein kinase, HGK, that specifically activates the c-Jun N-terminal kinase signaling pathway.
    J Biol Chem. 1999 Jan 22;274(4):2118-25 PMID: 9890973
  55. AP-1 in cell proliferation and survival.
    Oncogene. 2001 Apr 30;20(19):2390-400 PMID: 11402335
  56. Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation.
    Circulation. 2004 May 11;109(18):2227-33 PMID: 15117851
  57. The real estate of NOS signaling: location, location, location.
    Circ Res. 2003 Jun 27;92(12):1279-81 PMID: 12829613
  58. Nitric oxide and the enigma of cardiac hypertrophy.
    Bioessays. 2004 Jun;26(6):608-15 PMID: 15170858
  59. Myocardial infarction and regulatory myosin light chain.
    J Mol Cell Cardiol. 1997 Oct;29(10):2641-52 PMID: 9344759
  60. The role of modulatory calcineurin-interacting proteins in calcineurin signaling.
    Trends Cardiovasc Med. 2003 Jan;13(1):15-21 PMID: 12554096
  61. Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to injury.
    Circulation. 2000 Apr 25;101(16):1990-9 PMID: 10779467
  62. Microarray analysis of gene expression after transverse aortic constriction in mice.
    Physiol Genomics. 2004 Sep 16;19(1):93-105 PMID: 15292486
  63. Brief episode of ischemia activates protective genetic program in rat heart: a gene chip study.
    Cardiovasc Res. 2003 Aug 1;59(2):450-9 PMID: 12909328
  64. Calcineurin inhibition and cardiac hypertrophy: a matter of balance.
    Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):2947-9 PMID: 11248009
  65. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin.
    J Biol Chem. 1998 May 29;273(22):13367-70 PMID: 9593662
  66. TCDD-inducible poly(ADP-ribose) polymerase: a novel response to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Biochem Biophys Res Commun. 2001 Nov 30;289(2):499-506 PMID: 11716501
  67. Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium.
    Heart Fail Rev. 2004 Jan;9(1):43-51 PMID: 14739767
  68. Differential regulation of activator protein-1 and heat shock factor-1 in myocardial ischemia and reperfusion injury: role of poly(ADP-ribose) polymerase-1.
    Am J Physiol Heart Circ Physiol. 2004 Apr;286(4):H1408-15 PMID: 14670820
  69. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
    Anal Biochem. 1976 May 7;72:248-54 PMID: 942051
  70. Induction of activator protein 1 (AP-1) in macrophages by human immunodeficiency virus type-1 NEF is a cell-type-specific response that requires both hck and MAPK signaling events.
    J Mol Biol. 1999 Jul 2;290(1):21-35 PMID: 10388555
  71. Ventricular remodeling in a mouse model of myocardial infarction.
    Am J Physiol. 1998 May;274(5 Pt 2):H1812-20 PMID: 9612394
  72. Nitric oxide inhibits ornithine decarboxylase by S-nitrosylation.
    Biochem Biophys Res Commun. 1999 Aug 27;262(2):355-8 PMID: 10462479
  73. Ten ERK-related proteins in three distinct classes associate with AP-1 proteins and/or AP-1 DNA.
    J Biol Chem. 2001 Aug 24;276(34):32362-72 PMID: 11431474
  74. Cardiac hypertrophy: the good, the bad, and the ugly.
    Annu Rev Physiol. 2003;65:45-79 PMID: 12524460
  75. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox.
    Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4843-8 PMID: 12655043
  76. Nitric oxide inhibits ornithine decarboxylase via S-nitrosylation of cysteine 360 in the active site of the enzyme.
    J Biol Chem. 2001 Sep 14;276(37):34458-64 PMID: 11461922
  77. B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation.
    Circ Res. 2004 Mar 5;94(4):453-61 PMID: 14726474
  78. Nitric oxide and cardiac function: ten years after, and continuing.
    Circ Res. 2003 Sep 5;93(5):388-98 PMID: 12958142
  79. The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo.
    Circ Res. 2001 Jan 19;88(1):88-96 PMID: 11139479
  80. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy.
    Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2703-6 PMID: 11226303
  81. Effect of classic preconditioning on the gene expression pattern of rat hearts: a DNA microarray study.
    FEBS Lett. 2003 Feb 11;536(1-3):35-40 PMID: 12586334
Article Info
Journal
Mammalian genome : official journal of the International Mammalian Genome Society
Abbr.
Mamm Genome
ISSN
0938-8990
Published
2006-07-00
Epub
2006-00-14
Pages
701-15
Language
English
Region
United States
NLM ID
9100916
Subset
IM
Grants
NHLBI NIH HHS · 1 R15 HL71239-01 · United States
NCRR NIH HHS · P20 RR15640 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]